Condition
Peritoneal Metastases clinical trials and research
As of November 12, 2026, Find a Trial lists 10 Peritoneal Metastases clinical trials that are recruiting, at sites in 7 countries (most in China (3), United States (3), Sweden (2)). By phase: Phase 2 (3), Phase 1 (1), Phase 1/2 (1), Phase 3 (1). There are also 3 NIH-funded research projects on Peritoneal Metastases, with $2.3 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 10Clinical trials
- 3NIH research projects
- 7Countries
Newest Peritoneal Metastases clinical trials
All recruiting trials (10)
-
TROP2‑targeted CAR‑NK cells given into the abdomen and vein for colorectal cancer spread to the peritoneum
We will test whether giving TROP2‑directed CAR‑NK cells both into the abdominal cavity and into a vein, together with cetuximab, is safe and what dose is best for adults with colorectal cancer that has spread to the peritoneum.
-
Mass-based drug screening to guide personalized HIPEC for high-grade appendiceal and colorectal cancer with peritoneal spread.
This tests whether a lab-based mass response test on tumor biopsies can pick the best chemotherapy to use during repeated HIPEC for people with unresectable peritoneal metastases from high-grade appendiceal or colorectal cancer.
-
Direct injection of a modified vaccinia virus (vvDD-hIL2) into abdominal and gastrointestinal tumors
This trial will try a single direct injection of a modified vaccinia virus (vvDD-hIL2) into abdominal tumors to see if it is safe for adults with advanced metastatic gastrointestinal or peritoneal cancers who have not responded to standard treatments.
-
Monitoring blood markers to predict colorectal cancer recurrence after surgery
This study is testing if blood markers can help predict if colorectal cancer will come back after surgery in patients who have had their cancer completely removed.
-
Treatment for advanced gastric cancer with peritoneal metastasis using a combination of therapies
This study is testing a new combination of treatments for people with advanced gastric cancer that has spread to the abdomen to see if it can help slow down the disease and improve their health.
-
Using Pressurized Aerosol Chemotherapy for Peritoneal Cancer
This study is testing a new way to deliver chemotherapy directly into the abdomen to see if it helps people with advanced colorectal, gastric, or pancreatic cancers that can't be surgically removed.
-
Understanding biomarkers in metastatic colorectal cancer treatment
This study is trying to see how cancer changes during treatment in people with metastatic colorectal cancer and whether certain genetic markers can help tailor better treatment options for them.
-
Predicting peritoneal metastasis in gastric cancer using radiomics
This study is testing a new system that uses CT scans to help doctors predict the risk of cancer spreading in patients with advanced gastric cancer.
-
Treatment for colorectal cancer with hyperthermic chemotherapy
This study is testing if a new combination of chemotherapy drugs given after surgery can help people with colorectal cancer that has spread to the lining of the abdomen feel better and live longer compared to standard treatment.
-
Pressurized Chemotherapy for High Risk Colon Cancer Patients
This study is testing a new type of chemotherapy for patients with high-risk colon cancer to see if it can help prevent cancer from coming back after surgery and standard treatment.
NIH-funded research (3)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
TLR-based Nano-therapy delivered into the abdomen to fight peritoneal metastases
A new nano-therapy given directly into the abdomen uses TLR-agonist–modified particles to target and kill cancer cells in people with peritoneal metastases, especially from ovarian cancer.
-
Nanoparticle immune therapy for cancer spread in the abdomen
A tiny-particle immune treatment delivered into the abdomen to target ovarian and colorectal cancers that have spread to the peritoneal lining.
-
Using immune therapy to treat cancer spread in the abdomen
This study is looking at a new way to help people with ovarian and colorectal cancers that have spread to the abdomen by using tiny particles to boost the immune system's ability to fight the cancer directly where it is.
Related topics
Quick answers
How many Peritoneal Metastases clinical trials are recruiting right now?
10, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 7 countries. The most sites are in China (3 trials), United States (3 trials), Sweden (2 trials), India (1 trial), Hong Kong (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 1: 1, Phase 1/2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.